Referencias Bibliográficas sobre Probióticos Vaginales
Martin, Rebeca & Soberón, Nora & Camino, Fernando. (2008). La microbiota vaginal: composición, papel protector, patología asociada y perspectivas terapéuticas. Enfermedades infecciosas y microbiología clínica, ISSN 0213-005X, Vol. 26, Nº. 3, 2008, pags. 160-167. 26. 10.1157/13116753.
(1)Amant DCS, Valentin-Bon IE, Jerse AE. Inhibition of Neisseria gonorrhoeae by Lactobacillus species that are commonly isolated from the female genital tract. Infection and immunity. 2002;70:7169–7171. doi: 10.1128/IAI.70.12.7169-7171.2002
(2)Antonio MA, Rabe LK, Hillier SL. Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J Infect Dis. (2005) 192:394–8. 10.1086/430926
(3) Bohbot JM, Cardot JM. Vaginal impact of the oral administration of total freeze-dried culture of LCR 35 in healthy women. Infect Dis Obstet Gynecol. 2012;2012:503648. doi:10.1155/2012/503648
(4) Poupet C, Saraoui T, Veisseire P, et al. Lactobacillus rhamnosus Lcr35 as an effective treatment for preventing Candida albicans infection in the invertebrate model Caenorhabditis elegans: First mechanistic insights. PLoS One. 2019;14(11):e0216184. Published 2019 Nov 6. doi:10.1371/journal.pone.0216184
(5) J. M. Bohbot, E. Darai, F. Bretelle, G. Brami, C. Daniel, et al.. Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence. Journal of Gynecology Obstetrics and Human Reproduction, Elsevier, 2018, 47 (2), pp.81- ff10.1016/j.jogoh.2017.11.005ff. ffhal-01791646f
(6) de Vrese M, Laue C, Papazova E, Petricevic L, Schrezenmeir J. Impact of oral administration of four Lactobacillus strains on Nugent score - systematic review and meta-analysis. Benef Microbes. 2019;10(5):483-496. doi:10.3920/BM2018.0129
(7) Nabavi SF, Sureda A, Daglia M, Izadi M, Nabavi SM. Cranberry for Urinary Tract Infection: From Bench to Bedside. Curr Top Med Chem. 2017;17(3):331-339. doi:10.2174/1568026616666160829161031
(8) Dietz BM, Hajirahimkhan A, Dunlap TL, Bolton JL. Botanicals and Their Bioactive Phytochemicals for Women's Health. Pharmacol Rev. 2016;68(4):1026-1073. doi:10.1124/pr.115.010843
(9) Domenici L, Monti M, Bracchi C, et al. D-mannose: a promising support for acute urinary tract infections in women. A pilot study. Eur Rev Med Pharmacol Sci. 2016;20(13):2920-2925.
(10)Ying-H. Sheih, Bor-L. Chiang, Ling-H. Wang, Chuh-K. Liao & Harsharnjit S. Gill (2001) Systemic Immunity-Enhancing Effects in Healthy Subjects Following Dietary Consumption of the Lactic Acid Bacterium Lactobacillus rhamnosus HN001, Journal of the American College of Nutrition, 20:2, 149-156, DOI: 10.1080/07315724.2001.10719027
(11)Prescott SL, Wickens K, Westcott L, et al. Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection [published correction appears in Clin Exp Allergy. 2009 May;39(5):771]. Clin Exp Allergy. 2008;38(10):1606-1614. doi:10.1111/j.1365-2222.2008.03061.x
(12)De Alberti D, Russo R, Terruzzi F, Nobile V, Ouwehand AC. Lactobacilli vaginal colonisation after oral consumption of Respecta(®) complex: a randomised controlled pilot study. Arch Gynecol Obstet. 2015;292(4):861-867. doi:10.1007/s00404-015-3711-4
(13)Russo R, Superti F, Karadja E, De Seta F. Randomised clinical trial in women with Recurrent Vulvovaginal Candidiasis: Efficacy of probiotics and lactoferrin as maintenance treatment. Mycoses. 2019;62(4):328-335. doi:10.1111/myc.12883
(14) L. rhamnosus and L. fermentum can be delivered to the vagina by oral consumption, leading to a significant increase in vaginal lactobacilli (Morelli et al., 2004; Reid et al., 2003).
(15) Rossi A, Rossi T, Bertini M, Caccia G. The use of Lactobacillus rhamnosus in the therapy of bacterial vaginosis. Evaluation of clinical efficacy in a population of 40 women treated for 24 months. Arch Gynecol Obstet 2010;281:1065–9. http://dx.doi.org/10.1007/s00404-009-1287-6.
(16) Vicariotto F, Mogna L, Del Piano M. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis. A pilot study. J Clin Gastroenterol 2014;48:S106–12.
(17) De Seta, F., Parazzini, F., De Leo, R., Banco, R., Maso, G.P., De Santo, D., Sartore, A., Stabile, G., Inglese, S., Tonon, M. and Restaino, S., 2014. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study. European Journal of Obstetrics and Gynecology and Reproductive Biology 182: 136-139.
(18) Mastromarino P, Macchia S, Meggiorini L, Trinchieri V, Mosca L, Perluigi M, et al. Effectiveness of Lactobacillus containing vaginal tablets in the treatment of symptomatic bacterial vaginosis. Clin Microbiol Infect 2009;15:67–74.
(19) Petricevic L, Unger FM, Viernstein H, Kiss H. Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2008;141(1):54-57. doi:10.1016/j.ejogrb.2008.06.003
(20)Martinez RC, Franceschini SA, Patta MC, et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Letters in Applied Microbiology. 2009 Mar;48(3):269-274. DOI: 10.1111/j.1472-765x.2008.02477.x.
(21)Cianci A, Giordano R, Delia A, et al. Efficacia del Lactobacillus Rhamnosus GR-1 e del Lactobacillus Reuteri RC-14 nel trattamento e nella prevenzione delle recidive nelle vaginosi e nelle vaginiti batteriche [Efficacy of Lactobacillus Rhamnosus GR-1 and of Lactobacillus Reuteri RC-14 in the treatment and prevention of vaginoses and bacterial vaginitis relapses]. Minerva Ginecol. 2008;60(5):369-376.
(22)Petricevic L, Unger FM, Viernstein H, Kiss H. Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2008;141(1):54-57. doi:10.1016/j.ejogrb.2008.06.003
(23)Shams-Ghahfarokhi M, Shokoohamiri MR, Amirrajab N, et al. In vitro antifungal activities of Allium cepa, Allium sativum and ketoconazole against some pathogenic yeasts and dermatophytes. Fitoterapia. 2006;77(4):321-323. doi:10.1016/j.fitote.2006.03.014
(24)Bahadoran P, Rokni FK, Fahami F. Investigating the therapeutic effect of vaginal cream containing garlic and thyme compared to clotrimazole cream for the treatment of mycotic vaginitis. Iran J Nurs Midwifery Res. 2010;15(Suppl 1):343-349.
